Premium
A Photo‐Caged Platinum(II) Complex That Increases Cytotoxicity upon Light Activation
Author(s) -
Ciesienski Katie L.,
Hyman Lynne M.,
Yang Daniel T.,
Haas Kathryn L.,
Dickens Marina G.,
Holbrook Robert J.,
Franz Katherine J.
Publication year - 2010
Publication title -
european journal of inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.667
H-Index - 136
eISSN - 1099-0682
pISSN - 1434-1948
DOI - 10.1002/ejic.201000098
Subject(s) - chemistry , platinum , ligand (biochemistry) , amide , cytotoxicity , stereochemistry , cisplatin , metal , photochemistry , combinatorial chemistry , catalysis , receptor , organic chemistry , biochemistry , in vitro , medicine , surgery , chemotherapy
A novel platinum(II) photocaged complex called [Pt(cage)] has been prepared and characterized by X‐ray crystallography. The complex contains a photolabile nitrophenyl group incorporated into the backbone of a tetradentate ligand that contains two pyridyl and two amide nitrogen donor sites. The intact complex is unreactive toward ligand‐exchange reactions until activation with UV light cleaves the ligand backbone, releasing a Pt II complex that more readily exchanges its ligands, as verified by reaction with a methionine‐containing peptide. [Pt(cage)] is non‐toxic to MCF‐7 cells in the dark, whereas brief UV exposure induces cell death of human breast cancer MCF‐7 cells at a level approaching that of cisplatin. By using light to alter the coordination chemistry around the metal center, [Pt(cage)] represents a new strategy for potentially delivering metal‐based drugs in a site and time specific manner.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom